Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine with different epinephrine concentrations for third molar extraction
NCT02696369Phase 4Completed
- Sponsor
- Huons
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine, epinephrine in impacted third molar (I3M), sponsored by Huons. Started Dec 2014; status: completed.
02
Drugs
lidocaineepinephrine
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT02696369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02696369.